Capability of national reference laboratories in Latin America to detect emerging resistance mechanisms;Capacidad de los laboratorios nacionales de referencia en Latinoamérica para detectar mecanismos de resistencia emergentes

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 30, Issue 6, 2011, Pages 619-626

  Corso, Alejandra ^a   Guerriero, Leonor ^a   Pasterán, Fernando ^a   Ceriana, Paola ^a   Callejo, Raquel ^b   Prieto, Mónica ^b   Tuduri, Ezequiel ^h   Lopardo, Horacio ^c   Vay, Carlos ^d   Smayevsky, Jorgelina ^e   Tokumoto, Marta ^f   Álvarez, Jorge Matheu ^g   Pardo, Pilar Ramón ^g   Galas, Marcelo ^a  

^a Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^b INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^c Hospital de Pedriatría SAMIC   (Argentina)

^d HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^e CEMIC   (Argentina)

^f HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^g PAN AMERICAN HEALTH ORGANIZATION   (United States)

^h NONE

Author keywords

Drug and narcotic control; Drug resistance, Microbial; Enterobacteriacae; Klebsiella pneumoniae; Laboratory proficiency testing; Latin America; Quality control; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

BACTERIAL DISEASE; DISEASE CONTROL; DRUG RESISTANCE; FUTURE PROSPECT; INHIBITION; LABORATORY METHOD; MICROBIAL ACTIVITY; PERFORMANCE ASSESSMENT; PUBLIC HEALTH; QUALITY CONTROL;

ANTIBIOTIC RESISTANCE; ARTICLE; COMPARATIVE STUDY; ENTEROBACTER CLOACAE; ENZYMOLOGY; GENETICS; GOOD LABORATORY PRACTICE; HEALTH CARE QUALITY; KLEBSIELLA PNEUMONIAE; LABORATORY; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MULTIDRUG RESISTANCE; PHENOTYPE; PHYSIOLOGY; QUALITY CONTROL; REPRODUCIBILITY; SOUTH AND CENTRAL AMERICA; STANDARD; STAPHYLOCOCCUS AUREUS; STATISTICS; UTILIZATION REVIEW; WORLD HEALTH ORGANIZATION;

BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; KLEBSIELLA PNEUMONIAE; LABORATORIES; LABORATORY PROFICIENCY TESTING; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; PAN AMERICAN HEALTH ORGANIZATION; PHENOTYPE; QUALITY CONTROL; QUALITY INDICATORS, HEALTH CARE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

LATIN AMERICA;

ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; KLEBSIELLA PNEUMONIAE; STAPHYLOCOCCUS AUREUS;

EID: 84859954461     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/S1020-49892011001200021     Document Type: Article

References (30)

1. Schmunis G, Salvatierra-Gonzalez R. Birth of a public surveillanceSystem: PAHO combats the spread of antimicrobial resistance in Latin America. The APUA Newsletter Vol. 24 No 1, 2006.
2. Chaitram JM, Jevitt LA, Lary S, Tenover F, The WHO Antimicrobial Resistance Group. The World Health Organization's External Quality Assurance System Proficiency Testing Program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS Methods. JCM. 2003;41: 2372-7. (Pubitemid 36712438)
3. Corso A, Pasterán F, Ceriana P, Guerriero L, Callejo R, Prieto M, et al. Programa Latinoamericano de Control de Calidad en Bacteriología y Resistencia a los Antimicrobianos (LA-EQAS): siete anos de experiencia. Rev Panam Infectol. 2008;10(4 Supl 1):S26.37.
4. Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, et al. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006; 50(8):2880.2. (Pubitemid 44198721)
5. Marcano D, Pasterán F, Rapoport M, Faccone D, Ugarte C, Salgado N,et al. First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela. J Infect Dev Ctries. 2008;2(3):241.
6. Pasteran F, Otaegui L, Guerriero L, Radice G, Maggiora R, Rapoport M, et al. Klebsiella pneumoniae carbapenemase.2, Buenos Aires, Argentina. Emerg Infect Dis. 2008;14:1178.80. (Pubitemid 351920469)
7. Hawser SP, Bouchillon SK, Hoban DJ, Hackel M, Johnson JL, Badal RE. Klebsiella pneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece. Int J Antimicrob Agents. 2009;34(4):384.5.
8. Peirano G, Seki LM, Val Passos VL, Pinto MC, Guerra LR, Asensi MD. Carbapenemhydrolysing beta-lactamase KPC-2 in Klebsiella pneumoniaeisolated in Rio de Janeiro, Brazil. J Antimicrob Chemother. 2009;63(2):265.8.
9. Pasteran F, Corso A. Alerta: diseminación de KPC en Argentina. Actualización mayo de 2010. Buenos Aires: Programa Nacional de Control de Calidad en Bacteriología ( Argentina), Instituto Nacional de Enfermedades Infecciosas, ANLIS. "Dr. Carlos G. Malbrán" 2010.
10. Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis. 2010;16(9):1349.56.
11. Gómez S, Rapoport M, Togneri A, Viegas- Caetano J, Faccone D, Corso A, et al. Emergence of metallo-β-lactamases in Enterobacteriaceae from Argentina. Diagn Microbiol Infect Dis. 2011;69(1):94.7.
12. Gomez SA, Pasteran FG, Faccone D, Tijet N, Rapoport M, Lucero C,et al. Clonal dissemination of Klebsiella pneumoniae ST258 harboring KPC-2 in Argentina. Clin Microbiol Infect. 2011 Jun 11. doi: 10.1111/j.0691.2011.03600.x.
13. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. Sensitive screening tests for suspected class A carbapenemasa production in species of Enterobacteriaceae. J Clin Microbiol. 2009;47:1631.9.
14. Pasteran F, Mendez T, Rapoport M, Guerriero L, Corso A. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class a carbapenemase in species of Enterobacteriaceae by Incorporating Boronic Acid. J Clin Microbiol. 2010;48:1323.32
15. Clinical and Laboratory Standards Institute 2010. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010). M100-S20-U. Wayne, PA, USA.
16. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamaseproducing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003;41:4623.9. (Pubitemid 37259767)
17. Oliveira GA, Dell'Aquila AM, Masiero RL, Levy CE, Gomes MS, CuiL, et al. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin.Infect Control Hosp Epidemiol 2001;22:443/8. (Pubitemid 32889277)
18. De Paz M, Staneloni M, Ceriana P, Visus M, Greco G, Corso A, et al. Primer caso de Staphylococcus aureus con resistencia intermedia avancomicina (VISA) aislado en Argentina. X Congreso Argentino de la Sociedad Argentina de Infectologia 2010, Mar del Plata. Mayo 2010.
19. Errecalde L, Ceriana P, Gagetti P, Erbin M, Corso A, Duarte A, et al. Primer aislamiento en Argentina de Staphylococcus aureus meticilino resistente de la comunidad (CAMRSA) con sensibilidad intermedia a vancomicina (VISA) y no sensibilidad a Daptomicina (NSDAP). Presentación póster. XII Congreso Argentino de Microbiología, VI Congreso delaSociedad Argentina de Bacteriología, Micologiay Parasitología Clínica.SADEBAC, I Congreso de Microbiología Agricola y Ambiental.CABA.17.20 octubre.
20. Clinical and Laboratory Standards Institute 2010. Performance Standards for Antimicrobial Disk Susceptibility Test; Tenth Edition. Approved Standard. Document M2-A10. Wayne, PA, USA.
21. Clinical and Laboratory Standards Institute 2010. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Eighth Edition. Approved Standard. Document M7-A8.Wayne, PA,USA.
22. Clinical and Laboratory Standards Institute 2010. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. M100-S20. Wayne, PA, USA.
23. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. 2010.
24. Melano R, Corso A, Petroni A, Centron D, Orman B, Pereyra A, et al. Multiple antibioticresistance mechanisms including a novel combination of extended.spectrum B-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina. J Antimicrob Chemoter. 2003;53:36.42. (Pubitemid 36850082)
25. Sanger S, Micklen S, Coulson A. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci USA. 1977;74:5463.7.
26. Organización Panamericana de la Salud/Organización Mundial de la Salud. Anexo OPS/DPC/CD/274/03. Comité de Expertos para definir estándares de evaluación del desempeňo en el antibiograma (Kirby-Bauer)-áreas de inhibición o interpretación. Santiago,Chile, 24 al 26 de febrero de 2003. Informe Anual Regional de los Países Participantes en la Red de Monitoreo/Vigilancia de la Resistencia a los Antibióticos. Buenos Aires, Argentina. 10 al 13 de mayo, 2003.
27. Lovgren M, Talbot JA, Brandileone MC, Casagrande ST, Agudelo CI., Castaneda E, et al. Evolution of an international external quality assurance model to support laboratory investigation of Streptococcus pneumoniae. Developed for the SIREVA Project in Latin America, from 1993 to 2005. JCM. 2007;45:3184.90. (Pubitemid 47585638)
28. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;9:597.602.
29. Liu C, Bayer A, Cosgrove S, Daum R, Fridkin S, Gorwitz R, et al.Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Clin Infect Dis. 2011;52(3):285.92.
30. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC Jr, Craig WA, Billeter M, et al. Vancomycin therapeutic guidelines: a summary ofconsensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. J Clin Infect. Diseases. 2009;49:325.7.